On the morning of February 7, 2018, the National Food, Drug and Medical Device Inspection working Video and Telephone Conference was held in Beijing. Sun Xianze, the leader of CFDA, attended the meeting and made a speech. Li Bo, the Director of National Institutes for Food and Drug Control and secretary of the party committee, made the working report. The representatives from the Sichuan Institute for Food and Drug Control, Henan Provincial Institute of Food and Drug Control, Liaoning Testing Inspection Institute for Medical Devices, Beijing Municipal Center for Food Safety Monitoring and Risk Assessment and Jinan Center for Food and Drug Control made exchange speeches.
The conference summarized the inspection and testing tasks of food, drug and medical devices in 2017, analyzed the current situation in food and drug inspection and testing and clarified the work focus in 2018. The conference requires all the inspection and testing institutions to follow the Xi Jinping’s Thought on Socialism with Chinese Characteristics for a New Era, fully implement the spirits of 19th CPC National Congress, First and Second Plenary Sessions of the 19th Central Committee of the Chinese Communist Party, follow the general principle of making progress while working to keep performance stable, aim to ensure the food and drug safety of the masses, center on the improvement of food and drug quality and safety and deeply implement the food safety strategy. Besides, with focus on the 8 key tasks proposed in the National Food and Drug Regulatory Conference, it requires to implement all the work arrangements, deepen the reform of drug and medical device review and approval system, pay special attention to food and drug safety sampling inspection to keep the safety baseline and comprehensively enhance the construction of system capacity so as to push the food and drug surveillance and promote the sound and sustainable development of food and drug industry.
Mr. Sun Xianze spoke highly of the achievements made by the various inspection and testing institutions in the national food and drug surveillance system in 2017: first, make breakthroughs in the relevant work to push the reform of drug and medical device review and approval system under the consideration of the big picture; second, enhance risk prevention and control and further intensify the quality and safety sampling check; third, take active actions to push the identification and rectification of potential risks in the food and drug industry; fourth, emphasize basic capacity building to improve the scientific and professional level of surveillance.
For the work focus in 2018, Li Bo requires that: first, continue to support the deepening of review and approval reform and the encouragement of innovation; second, follow the problem-orientated principle to make inspection and risk prevention and control earnestly; third, follow the guidance of innovation thought to carry out standard researches and develop supplementary inspection approaches; fifth, enhance the investigational researches to appropriately implement the cessation of drug and medical device inspection charges; sixth, enhance education and training and intensify the construction of talent cultivation system; seventh, reinforce the discipline construction and well implement the construction of the Party conduct and of an honest and clean government.
The invited and present guests seated in the main venue include the leaders from the General Office, Department of Food Safety Supervision III, Department of Drug and Cosmetics Registration, Department of Medical Device Registration, Department of Drug and Cosmetics Supervision, Department of Medical Device Supervision, Department of Science, Technology and Standards and Department of Media and Publicity under the China Food and Drug Administration and competent leaders from the Chinese Pharmacopoeia Commission, Center for Drug Evaluation, Center for Food and Drug Inspection, Center for Medical Device Evaluation and Beijing Food and Drug Administration under the CFDA. The representatives present in the main venue include all the above-middle-level cadres from the Beijing Institute of Drug Control, Beijing Institute of Medical Device Testing, Medical Devices Quality Supervision and Testing Centre of Peking University, Beijing Institute of Drug Packing Material Control, Beijing Municipal Center for Food Safety Monitoring and Risk Assessment, Institute for Food and Drug Control under the Health Bureau of Logistics and Security Department of the Central Military Commission and the National Institute for the Control of Pharmaceutical and Biological Products. Leaders of provincial (district or municipal) food and drug administrations in charge of food, drug and medical device inspection and representatives of provincial institutes (centers) for food, drug, medical device, pharmaceutical packaging material and accessory material control and district or municipal institutes for food and drug control under the provincial authorities attended the conference at over 30 branch venues.
The conference summarized the inspection and testing tasks of food, drug and medical devices in 2017, analyzed the current situation in food and drug inspection and testing and clarified the work focus in 2018. The conference requires all the inspection and testing institutions to follow the Xi Jinping’s Thought on Socialism with Chinese Characteristics for a New Era, fully implement the spirits of 19th CPC National Congress, First and Second Plenary Sessions of the 19th Central Committee of the Chinese Communist Party, follow the general principle of making progress while working to keep performance stable, aim to ensure the food and drug safety of the masses, center on the improvement of food and drug quality and safety and deeply implement the food safety strategy. Besides, with focus on the 8 key tasks proposed in the National Food and Drug Regulatory Conference, it requires to implement all the work arrangements, deepen the reform of drug and medical device review and approval system, pay special attention to food and drug safety sampling inspection to keep the safety baseline and comprehensively enhance the construction of system capacity so as to push the food and drug surveillance and promote the sound and sustainable development of food and drug industry.
Mr. Sun Xianze spoke highly of the achievements made by the various inspection and testing institutions in the national food and drug surveillance system in 2017: first, make breakthroughs in the relevant work to push the reform of drug and medical device review and approval system under the consideration of the big picture; second, enhance risk prevention and control and further intensify the quality and safety sampling check; third, take active actions to push the identification and rectification of potential risks in the food and drug industry; fourth, emphasize basic capacity building to improve the scientific and professional level of surveillance.
For the work focus in 2018, Li Bo requires that: first, continue to support the deepening of review and approval reform and the encouragement of innovation; second, follow the problem-orientated principle to make inspection and risk prevention and control earnestly; third, follow the guidance of innovation thought to carry out standard researches and develop supplementary inspection approaches; fifth, enhance the investigational researches to appropriately implement the cessation of drug and medical device inspection charges; sixth, enhance education and training and intensify the construction of talent cultivation system; seventh, reinforce the discipline construction and well implement the construction of the Party conduct and of an honest and clean government.
The invited and present guests seated in the main venue include the leaders from the General Office, Department of Food Safety Supervision III, Department of Drug and Cosmetics Registration, Department of Medical Device Registration, Department of Drug and Cosmetics Supervision, Department of Medical Device Supervision, Department of Science, Technology and Standards and Department of Media and Publicity under the China Food and Drug Administration and competent leaders from the Chinese Pharmacopoeia Commission, Center for Drug Evaluation, Center for Food and Drug Inspection, Center for Medical Device Evaluation and Beijing Food and Drug Administration under the CFDA. The representatives present in the main venue include all the above-middle-level cadres from the Beijing Institute of Drug Control, Beijing Institute of Medical Device Testing, Medical Devices Quality Supervision and Testing Centre of Peking University, Beijing Institute of Drug Packing Material Control, Beijing Municipal Center for Food Safety Monitoring and Risk Assessment, Institute for Food and Drug Control under the Health Bureau of Logistics and Security Department of the Central Military Commission and the National Institute for the Control of Pharmaceutical and Biological Products. Leaders of provincial (district or municipal) food and drug administrations in charge of food, drug and medical device inspection and representatives of provincial institutes (centers) for food, drug, medical device, pharmaceutical packaging material and accessory material control and district or municipal institutes for food and drug control under the provincial authorities attended the conference at over 30 branch venues.